Involvement of M1-muscarinic acetylcholine receptors, protein kinase C and mitogen-activated protein kinase in the effect of huperzine A on secretory amyloid precursor protein-α

NeuroReport

Volumn 18, Issue 7, 2007, Pages 689-692

  Yan, Han ^a   Zhang, Hai Yan ^a   Tang, Xi Can ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Amyloid precursor protein; Huperzine A; M1 muscarinic acetylcholine receptor; Mitogen activated protein kinase; Protein kinase C

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN ALPHA; HUPERZINE A; MITOGEN ACTIVATED PROTEIN KINASE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR ANTAGONIST; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; ATTENUATION; CELL LINE; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UPREGULATION;

CELL LINE; CHOLINESTERASE INHIBITORS; ENZYME INHIBITORS; HUMANS; MECAMYLAMINE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCARINIC ANTAGONISTS; NICOTINIC ANTAGONISTS; PROTEIN KINASE C; RECEPTOR, MUSCARINIC M1; SCOPOLAMINE; SERUM AMYLOID A PROTEIN; SESQUITERPENES; UP-REGULATION;

EID: 34247199363     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3280c1e28c     Document Type: Article

References (20)

1. Giacobini E. Cholinergic function and Alzheimer's disease. Int J Geriatr Psychiatry 2003; 18:S1-S5.
2. Sisodia SS. Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci U S A 1992; 89:6075-6079.
3. Racchi M, Mazzucchelli M, Porrello E, Lanni C, Govoni S. Acetyl-cholinesterase inhibitors: novel activities of old molecules. Pharmacol Res 2004; 50:441-451.
4. Kim C, Jang CH, Bang JH, Jung MW, Joo I, Kim SU, et al. Amyloid precursor protein processing is separately regulated by protein kinase C and tyrosine kinase in human astrocytes. Neurosci Lett 2002; 324:185-188.
5. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 1992; 258:304-307.
6. Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, et al. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc Natl Acad Sci U S A 1992; 89:10075-10078.
7. Wang R, Yan H, Tang XC. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol Sin 2006; 27:1-26.
8. Mori F, Lai CC, Fusi F, Giacobini E. Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. NeuroReport 1995; 6:633-636.
9. Pakaski M, Rakonczay Z, Kasa P. Reversible and irreversible acetyl-cholinesterase inhibitors cause changes in neuronal amyloid precursor protein processing and protein kinase C level in vitro. Neurochem Int 2001; 38:219-226.
10. Pakaski M, Rakonczay Z, Fakla I, Papp H, Kasa P. In vitro effects of metrifonate on neuronal amyloid precursor protein processing and protein kinase C level. Brain Res 2000; 863:266-270.
11. Zhang HY, Yan H, Tang XC. Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intra-cerebroventricular beta-amyloid-(1-40) infused rats and human embryonic kidney 293 Swedish mutant cells. Neurosci Lett 2004; 360:21-24.
12. Wang YE, Yue DX, Tang XC. Anti-cholinesterase activity of huperzine A. Acta Pharmacol Sin 1986; 7:110-113.
13. Fisher A, Pittel Z, Haring R, Bar-Ner N, Kliger-Spatz M, Natan N, et al. M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy. J Mol Neurosci 2003; 20:349-356.
14. Zhang HY, Tang XC. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease. Trends Pharmacol Sci 2006; 27:619-625.
15. Blanc EM, Kelly JF, Mark RJ, Waeg G, Mattson MP. 4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible action on G alpha(q/11). J Neurochem 1997; 69:570-580.
16. Nitsch RM, Slack BE, Farber SA, Borghesani PR, Schulz JG, Kim C, et al. Receptor-coupled amyloid precursor protein processing. Ann N Y Acad Sci 1993; 695:122-127.
17. Caporaso GL, Gandy SE, Buxbaum JD, Ramabhadran TV, Greengard P. Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci U S A 1992; 89:3055-3059.
18. Wang ZF, Tang LL, Yan H, Wang YJ, Tang XC. Effects of huperzine A on memory deficits and neurotrophic factors production after transient cerebral ischemia and reperfusion in mice. Pharmacol Biochem Behav 2006; 83:603-611.
19. Villa A, Latasa MJ, Pascual A. Nerve growth factor modulates the expression and secretion of beta-amyloid precursor protein through different mechanisms in PC12 cells. J Neurochem 2001; 77:1077-1084.
20. Haring R, Fisher A, Marciano D, Pittel Z, Kloog Y, Zuckerman A, et al. Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion. J Neurochem 1998; 71:2094-2103.